SCHEMBL3765048

SCHEMBL3765048

C=C(OCCCC)c1c(N2CCOCC2)sc2c1CC(C)(C)CC2=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.42
PIK3CA P42336 1/20 0.42
PIK3CB P42338 1/20 0.42
PIK3CG P48736 1/20 0.42
SMN1; SMN2 Q16637 4/20 0.40
MAPT P10636 4/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
KDM4E B2RXH2 2/20 0.39
GLA P06280 1/20 0.39
POLB P06746 2/20 0.38
LMNA P02545 2/20 0.38
ALDH1A1 P00352 7/20 0.36
USP2 O75604 1/20 0.33
ALOX15 P16050 1/20 0.33
BRD4 O60885 1/20 0.32
MEN1 O00255 1/20 0.32
TSHR P16473 1/20 0.32
CASP1 P29466 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3758593 0.85 PIK3CD (0.43) PIK3CDPIK3CAPIK3CBPIK3CGSMN1; SMN2
SCHEMBL3760327 0.79 PIK3CA (0.50) PIK3CDPIK3CAPIK3CBPIK3CGSMN1; SMN2
SCHEMBL3766924 0.79 PIK3CD (0.50) PIK3CDPIK3CAPIK3CBPIK3CGSMN1; SMN2
SCHEMBL3757634 0.78 PIK3CD (0.47) PIK3CDPIK3CAPIK3CBPIK3CGSMN1; SMN2
SCHEMBL3759845 0.78 PIK3CA (0.49) PIK3CDPIK3CAPIK3CBPIK3CGSMN1; SMN2
SCHEMBL3758728 0.74 PIK3CA (0.52) PIK3CDPIK3CAPIK3CBPIK3CGSMN1; SMN2
SCHEMBL3764741 0.74 PIK3CA (0.52) PIK3CDPIK3CAPIK3CBPIK3CGSMN1; SMN2
SCHEMBL3764964 0.74 PIK3CA (0.55) PIK3CDPIK3CAPIK3CBPIK3CGSMN1; SMN2
SCHEMBL3766105 0.74 PIK3CA (0.52) PIK3CDPIK3CAPIK3CBPIK3CGSMN1; SMN2
SCHEMBL16161771 0.72 PIK3CD (0.43) PIK3CDPIK3CAPIK3CBPIK3CGSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA PIK3CD 9/4885PIK3CA 3/4885PIK3CB 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.